Clinical Pharmacokinetic Considerations in the Use of Plasma Expanders
- 1 February 1987
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 12 (2), 123-135
- https://doi.org/10.2165/00003088-198712020-00003
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Pharmacological effects produced by the acute and chronic administration of hydroxyethyl starchJournal of Clinical Apheresis, 1984
- Distribution and clearance from the body of an oxypolygelatin plasma substitute determined by radioactive tracer study in chimpanzees.1983
- Die Elimination von Hydroxyäthylstärke 200/0,5, Dextran 40 und OxypolygelatineKlinische Wochenschrift, 1982
- PHARMACOKINETICS OF LOW-MOLECULAR (MONO-VALENT) DEXTRAN (DX-1) IN VOLUNTEERS1981
- Post-transfusion survival of hydroxyethyl starch 450/0·70 in man: a long-term studyJournal of Clinical Pathology, 1980
- The dextrans--clinical data.1980
- Hydroxyethyl starch. An agent for hypovolaemic schock treatment II. Urinary excretion in normal volunteers following three consecutive daily infusions.British Journal of Clinical Pharmacology, 1977
- [Quantitative micro determination of dextran. I. In body fluids].1968
- Automated analyses of sugar phosphatesAnalytical Biochemistry, 1964
- THE RENAL EXCRETION OF LOW MOLECULAR WEIGHT DEXTRAN.1964